F5 (FFIV) Earnings Analysis
F5 (FFIV) next reports earnings on 2026-07-27, consensus EPS 3.98 USD. Last quarter (2026-01-27) it beat with EPS 4.45 USD vs 3.64 USD est (+22.3%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 32.52.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does FFIV next report earnings?
| Next earnings date | 2026-07-27 |
|---|---|
| Consensus EPS estimate | 3.98 USD |
| Revenue estimate | 0.83B |
FFIV earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-01-27 | 4.45 USD | 3.64 USD | +22.3% | Beat |
| 2025-10-27 | 4.39 USD | 3.97 USD | +10.6% | Beat |
| 2025-04-28 | 3.42 USD | 3.1 USD | +10.3% | Beat |
| 2025-01-28 | 3.84 USD | 3.36 USD | +14.3% | Beat |
| 2024-10-28 | 3.67 USD | 3.45 USD | +6.4% | Beat |
| 2024-07-29 | 3.36 USD | 2.97 USD | +13.1% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
FFIV valuation and analyst view
| Trailing P/E | 32.52 |
|---|---|
| Trailing EPS | 12.489 USD |
| Price / book | 6.22 |
| Dividend yield | 0.00% |
| Market cap | 22.72B |
| Analyst consensus | Hold (25 buy / 33 hold / 3 sell) |
| Avg price target | 405.67 USD |
Related research pages
Frequently asked questions
When is F5 (FFIV)'s next earnings date?
F5 is next scheduled to report on 2026-07-27, with a consensus EPS estimate of 3.98 USD and revenue estimate of 0.83B.
Did FFIV beat earnings last quarter?
In its 2026-01-27 report, FFIV posted EPS of 4.45 USD versus a 3.64 USD estimate — a beat of 22.3%.
What is FFIV's earnings track record?
Over the last 6 reported quarters with consensus data, FFIV beat estimates 6 times (100%).
What is FFIV's current P/E ratio and EPS?
FFIV trades at a trailing P/E of 32.52 on trailing EPS of 12.488784651195598 USD.
What do analysts rate FFIV?
Analyst consensus is "Hold" across 61 ratings (1 strong buy, 24 buy, 33 hold, 3 sell, 0 strong sell). Average 12-month price target: 405.67 USD.